Guy M. Goodwin

1 presentation

• W114. DURABILITY OF EFFICACY AND SAFETY OF COMP360 PSILOCYBIN FOR TREATMENT-RESISTANT DEPRESSION (TRD) ACROSS 26 WEEKS IN A DOUBLE-BLIND, RANDOMIZED, CONTROLLED PHASE 3 STUDY

  2026 ASCP Annual Meeting